View in EDS

Circulating Tumor DNA to Predict Surgical Outcome after Neoadjuvant Chemoradiation for Borderline Resectable/Locally Advanced Pancreatic Cancer.

Saved in:
Bibliographic Details
Title: Circulating Tumor DNA to Predict Surgical Outcome after Neoadjuvant Chemoradiation for Borderline Resectable/Locally Advanced Pancreatic Cancer.
Authors: McDuff, S.1, Parikh, A.S.2, Hazar-Rethinam, M.2, Zheng, H.3, Van Seventer, E.2, Nadres, B.2, Lennerz, J.K.4, Ryan, D.P.2, Weekes, C.2, Clark, J.W.2, Casti, C. Fernandez-del2, Ferrone, C.R.2, Lillemoe, K.2, Goyal, L.2, Zhu, A.X.2, Wo, J.Y.5, Blaszkowsky, L.S.2, Allen, J.N.2, Corcoran, R.6, Hong, T.S.7
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS134-S134. 1p.
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2018.06.330